A core facility for the synthesis of combinatorial peptide libraries will be established. The core facility will be equipped with an Advanced ChemTech model 357 Biomolecular Synthesizer. This instrument has the capability to synthesize sets of peptides in parallel and also in the spit-and-pool mode to afford combinatorial peptide libraries. The instrument will be operated and maintained by a dedicated research scientist who will implement the combinatorial peptide synthesis methodology. The core facility will be used by students and post-doctoral investigators from the component projects as a resource to prepare peptide libraries directed toward their respective targets. The research scientist in the core will serve as the focus of the combinatorial methodology and provide advice on the library synthesis, screening, and analysis to the individual project. The goal of the core facility is to facilitate the generation of chemical diversity using the will established chemistry of peptide bond formation. Natural and non-natural residues will readily be incorporated during combinatorial ligand synthesis. The sequencing of peptides beads after screening will be facilitated by using a partial termination strategy that will allow peptide sequence to be determined from a single mass spectrum. This approach allows the rapid identification of new ligands for their respective targets for each component. In addition, the combinatorial approach will allow the generation of rapid feedback to test the theoretical design criteria developed using computational methods.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM056552-03
Application #
6204305
Study Section
Project Start
1999-08-01
Project End
2000-07-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
076580745
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Suntoke, Tara R; Chan, David C (2005) The fusion activity of HIV-1 gp41 depends on interhelical interactions. J Biol Chem 280:19852-7
Koshiba, Takumi; Chan, David C (2003) The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions. J Biol Chem 278:7573-9
Klein, R Matthew; Zheng, Mingzhe; Ambesi, Anthony et al. (2003) Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J Cell Sci 116:4663-74
Sia, Samuel K; Kim, Peter S (2003) Protein grafting of an HIV-1-inhibiting epitope. Proc Natl Acad Sci U S A 100:9756-61
Dayie, Kwaku T; Brodsky, Alexander S; Williamson, James R (2002) Base flexibility in HIV-2 TAR RNA mapped by solution (15)N, (13)C NMR relaxation. J Mol Biol 317:263-78
Carlomagno, Teresa; Hennig, Mirko; Williamson, James R (2002) A novel PH-cT-COSY methodology for measuring JPH coupling constants in unlabeled nucleic acids. application to HIV-2 TAR RNA. J Biomol NMR 22:65-81
Sarkar, Casim A; Lowenhaupt, Ky; Horan, Thomas et al. (2002) Rational cytokine design for increased lifetime and enhanced potency using pH-activated ""histidine switching"". Nat Biotechnol 20:908-13
Lee, L P; Tidor, B (2001) Optimization of binding electrostatics: charge complementarity in the barnase-barstar protein complex. Protein Sci 10:362-77
Malashkevich, V N; Singh, M; Kim, P S (2001) The trimer-of-hairpins motif in membrane fusion: Visna virus. Proc Natl Acad Sci U S A 98:8502-6
Eckert, D M; Kim, P S (2001) Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 70:777-810

Showing the most recent 10 out of 23 publications